Simplified Chinese
scroll down
24
2025-06
The summer sun blazes, and waves of heat sweep across the landscape. To effectively ensure heat‑related safety and cooling measures during periods of extreme temperatures, mitigate potential health and safety risks to employees, and safeguard their rights to safety and well‑being, on the morning of June 18, 2025, Cao Zijian, Deputy Secretary of the Party Working Committee and Chairman of the Trade Union at the Daxing Biomedical Base, led union staff—bearing heartfelt concern and warm greetings—to Minhai Biotechnology Co., Ltd. They presented frontline workers who remain on duty despite the sweltering heat with care packages containing practical heat‑relief items such as watermelon and Lianhua Qingwen herbal remedies, bringing a touch of coolness and comfort to the scorching summer days. During the visit, Secretary Cao warmly…
19
2025-06
On the afternoon of June 6, 2025, the MINI Marathon Relay—themed “Uniting the ‘Min’ Spirit, Striding Toward the Future”—concluded successfully on the plaza in front of Building No. 1 at Minhai Biologics’ International Vaccine Industrial Base. Employees’ enthusiastic spirit and collaborative teamwork highlighted the company’s dynamic, forward‑looking corporate culture. At the opening ceremony, General Manager Nie delivered a speech, underscoring the company’s people‑oriented development philosophy and encouraging staff to relieve stress and strengthen team cohesion through physical activity. Following the start of the race, participating teams quickly found their rhythm. A professional coach led the warm‑up session, ensuring that employees were in peak condition for the competition; the event itself was lively and engaging, with each team showcasing their ingenuity…
16
2025-06
1. Project Name: Key Technologies for the Development of a Superbug Vaccine and Their Promotion and Application 2. Nominating Entity: Chongqing Municipality 3. Category and Level of Nomination Award: National Invention Award—First Prize or Second Prize 4. List of Major Intellectual Property Rights, Standards, and Specifications: | Intellectual Property (Standard) Category | Specific Name of Intellectual Property (Standard) | Country (Region) | Authorization Number (Standard Number) | Date of Authorization (Standard Publication) | Certificate Number (Standard Approval and Publication Authority) | Right Holder (Standard Drafting Organization) | Inventor (Standard Drafter) | Patent (Standard) | Validity Status | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Invention Patent (Standard) | A Staphylococcus aureus Vaccine and Its Preparation Method | China | ZL2 |
16
2025-06
Public Notice Regarding Nomination Projects for the 2025 National Science and Technology Awards
Public Notice Regarding Nominations for the 2025 National Science and Technology Awards In accordance with Document No. 4 [2025] issued by the National Science and Technology Awards Office, “Notice on the Nomination Process for the 2025 National Science and Technology Awards,” and in order to ensure the smooth submission of applications for the 2025 National Science and Technology Awards, uphold the fairness of the awards, and strengthen public oversight of scientific and technological award activities, we hereby announce the project “Key Technologies for the Development of a Superbug Vaccine and Its Promotional Application,” in which our company has participated. The public notice period is from June 16 to June 20, 2025. During this period, should you have any objections to the nominated project, please submit your concerns to…
10
2025-06
In accordance with the requirements of the Measures for Public Participation in Environmental Impact Assessment (Order No. 4 of the Ministry of Ecology and Environment), the following information regarding the environmental impact assessment for the “Construction Project of the Production Workshop for Minhai Biotechnology’s Quadrivalent Inactivated Enterovirus Vaccine (Vero Cell)” is hereby made public: I. Project Overview Project Name: Construction of the Production Workshop for Minhai Biotechnology’s Quadrivalent Inactivated Enterovirus Vaccine (Vero Cell) Project Nature: Expansion Construction Site: Building No. 2, Zone 2B, North Factory Area, Beijing Minhai Biotechnology Co., Ltd., No. 35 Simiao Road, Bio‑Pharmaceutical Industry Base, Daxing District, Beijing Project Undertaker: Beijing Minhai Biotechnology Co., Ltd. Scope of Construction: This project will utilize…
Contact Information
Customer Service Hotline
4001899806
Phone number
010-59613600
Official Website
Company Address
No. 35 Simiao Road and No. 25 Tianfu Street, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing
WeChat Official Account
0
%